
Madrigal Pharmaceuticals to Announce Q4 and Full-Year 2024 Results with Live Webcast
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) has announced the release of its fourth-quarter and full-year 2024 financial results, scheduled for Wednesday, February 26, 2025, before the U.S. financial …
Madrigal Pharmaceuticals to Announce Q4 and Full-Year 2024 Results with Live Webcast Read More